Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport injection technique comparison in post-stroke or post-traumatic brain injury upper limb spasticity
2011-005375-16Phase 3Terminated
- Sponsor
- Ipsen
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in upper extremity spasticity, Muscle spasm, sponsored by Ipsen. Started Dec 2011; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
upper extremity spasticityMuscle spasm
Beyond the preview
Go deeper on 2011-005375-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005375-16.